Wells Fargo & Company »

Carisma Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $24k 8.2k 2.93
2023-09-30 $30k 7.0k 4.23
2023-06-30 $93k 11k 8.77